These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 9425584)

  • 1. Polycystic ovary syndrome associated with treatment with the anticonvulsant sodium valproate.
    Sharma S; Jacobs HS
    Curr Opin Obstet Gynecol; 1997 Dec; 9(6):391-2. PubMed ID: 9425584
    [No Abstract]   [Full Text] [Related]  

  • 2. [The dangers of valproate in women].
    Isojärvi J
    Duodecim; 1998; 114(9):825, 827. PubMed ID: 11524801
    [No Abstract]   [Full Text] [Related]  

  • 3. Appropriate clinical management of women taking valproate.
    Piontek CM; Wisner KL
    J Clin Psychiatry; 2000 Mar; 61(3):161-3. PubMed ID: 10817097
    [No Abstract]   [Full Text] [Related]  

  • 4. More on valproate and polycystic ovaries.
    Johnston HF
    J Am Acad Child Adolesc Psychiatry; 1999 Apr; 38(4):354. PubMed ID: 10199101
    [No Abstract]   [Full Text] [Related]  

  • 5. Valproate and polycystic ovaries.
    Eberle AJ
    J Am Acad Child Adolesc Psychiatry; 1998 Oct; 37(10):1009. PubMed ID: 9785710
    [No Abstract]   [Full Text] [Related]  

  • 6. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
    Luef G; Abraham I; Haslinger M; Trinka E; Seppi K; Unterberger I; Alge A; Windisch J; Lechleitner M; Bauer G
    J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate and the polycystic ovarian syndrome: final thoughts.
    Herzog AG; Schachter SC
    Epilepsia; 2001 Mar; 42(3):311-5. PubMed ID: 11442145
    [No Abstract]   [Full Text] [Related]  

  • 8. On the association between valproate and polycystic ovary syndrome: a response and an alternative view.
    Isojärvi JI; Taubøll E; Tapanainen JS; Pakarinen AJ; Laatikainen TJ; Knip M; Myllylä VV
    Epilepsia; 2001 Mar; 42(3):305-10. PubMed ID: 11442144
    [No Abstract]   [Full Text] [Related]  

  • 9. Preliminary observations on valproate and cystic ovaries: letter to editor.
    Chakravarty A
    Neurol India; 2002 Mar; 50(1):106-7. PubMed ID: 11960167
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy.
    Pylvänen V; Pakarinen A; Knip M; Isojärvi J
    Epilepsy Behav; 2006 May; 8(3):643-8. PubMed ID: 16600693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case reports.
    Betts T
    Seizure; 2001 Apr; 10(3):229-34. PubMed ID: 11437624
    [No Abstract]   [Full Text] [Related]  

  • 12. Polycystic ovary syndrome in women using valproate: a review.
    Bilo L; Meo R
    Gynecol Endocrinol; 2008 Oct; 24(10):562-70. PubMed ID: 19012099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A putative relationship between valproic acid and polycystic ovarian syndrome: implications for treatment of women with seizure and bipolar disorders.
    Joffe H; Hall JE; Cohen LS; Taylor AE; Baldessarini RJ
    Harv Rev Psychiatry; 2003; 11(2):99-108. PubMed ID: 12868510
    [No Abstract]   [Full Text] [Related]  

  • 14. Reproductive endocrine function in women with epilepsy: the role of epilepsy type and medication.
    Löfgren E; Mikkonen K; Tolonen U; Pakarinen A; Koivunen R; Myllyla VV; Tapanainen JS; Isojärvi JI
    Epilepsy Behav; 2007 Feb; 10(1):77-83. PubMed ID: 17098479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polycystic ovary syndrome and valproic acid].
    Ribacoba Montero R; Martínez-Faedo C; Salas-Puig J
    Rev Neurol; 2003 Nov 16-30; 37(10):975-82. PubMed ID: 14634930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weight gain in children treated with valproate.
    Sharpe C; Wolfson T; Trauner DA
    J Child Neurol; 2009 Mar; 24(3):338-41. PubMed ID: 19258293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of anticonvulsant medication on ovarian function in a group of women with epilepsy who have only ever taken one anticonvulsant compared with a group of women without epilepsy.
    Betts T; Yarrow H; Dutton N; Greenhill L; Rolfe T
    Seizure; 2003 Sep; 12(6):323-9. PubMed ID: 12915077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of valproic acid on reproductive endocrine functions in Turkish women with epilepsy.
    Gorkemli H; Genc BO; Dogan EA; Genc E; Ozdemir S
    Gynecol Obstet Invest; 2009; 67(4):223-7. PubMed ID: 19246930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium valproate, hyperandrogenism and altered ovarian function in Indian women with epilepsy: a prospective study.
    Prabhakar S; Sahota P; Kharbanda PS; Siali R; Jain V; Lal V; Khurana D
    Epilepsia; 2007 Jul; 48(7):1371-7. PubMed ID: 17441994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy.
    Isojärvi JI; Rättyä J; Myllylä VV; Knip M; Koivunen R; Pakarinen AJ; Tekay A; Tapanainen JS
    Ann Neurol; 1998 Apr; 43(4):446-51. PubMed ID: 9546324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.